工程CAR-T细胞用于固体瘤:双特异性抗原向,瘤微环境调制和毒性控制
Tanvi Premchandani, Mohammad Qutub, Amol Tatode1
1Department of Pharmaceutics, Bhoyar College of Pharmacy, Smt. Kishoritai, Kamptee, Nagpur, Maharashtra, India. aatatode@gmail.com.
Immunologic research
|September 20, 2025
概括
化学抗原受体T (CAR-T) 细胞疗法对固体瘤具有前景,新的设计可以改善向和安全性. 克服分娩和瘤微环境中的挑战是CAR-T 2.0进步的关键.
科学领域:
- 免疫治疗是一种免疫疗法.
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 化学抗原受体T (CAR-T) 细胞疗法已经改变了血液癌症治疗.
- 显著的挑战阻碍了CAR-T在固体瘤中的有效性,包括抗原异质性,免疫抑制性瘤微环境和毒性.
研究的目的:
- 审查对固体瘤的CAR-T细胞疗法的最新进展.
- 突出CAR-T设计,交付系统和安全机制的创新.
主要方法:
- 关于CAR-T代,共刺激域和细胞因子武装TRUCK的审查.
- 病毒和非病毒传递系统的比较 (例如,CRISPR,mRNA电穿孔).
- 讨论克服固体瘤障碍的策略,包括双重向,瘤受限制的CAR和TME调制.
主要成果:
- 下一代CAR-T设计包括纳米体和先进的安全开关 (例如,iCasp9).
- 克里斯普尔技术可以进行多重基因编辑,以提高CAR-T特异性.
- 装甲CAR和工程化基因受体改善了瘤透和微环境重塑.
结论:
- 固体瘤的CAR-T疗法通过先进的设计和输送系统显示出有前途.
- 克服制造复杂性,非目标效应和监管障碍对于临床翻译至关重要.
- 未来的方向包括人工智能驱动的设计和针对CAR-T 2.0.0的个性化新抗原准.
相关概念视频
01:27Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K